The New Normal: Next steps for payers in response to CMS regulatory changes to Medicare Advantage

episode

Alvarez & Marsal: Healthcare Industry Group not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Alvarez & Marsal: Healthcare Industry Group

Episode 10: Clover Health's Blueprint for Sustainable Growth 15 min · 30 Jun 2026

All episodes from Alvarez & Marsal: Healthcare Industry Group →

Report any issue

Source

Recorded25 Jul 2023

Publisherfeeds.castos.com ↗

Handlerec:14026802

Show notes

Earlier this year, CMS finalized multiple rules that impact MAOs, with significant ramifications to procedures for RADV audits. Listen as A&M Healthcare Industry Group Managing Director, Jeff de Los Reyes and Christina Steiner, Senior Director, talk with Brian Stimson, Partner at McDermott Will & Emery, to discuss actions that plans should consider in advance of these changes.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.